FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Meeting on Outsourcing Facilities Office Stock

[ Price : $8.95]

Federal Register notice: FDA announces a 5/21 public meeting entitled FDAs Proposed Current Good Manufacturing Practice Policies f...

Revised GMP Guide for Outsourcing Facilities

[ Price : $8.95]

Federal Register notice: FDA makes available a revised draft guidance entitled Current Good Manufacturing Practice Guidance for H...

4 New Biosimilar Guidances

[ Price : $8.95]

FDA commissioner Scott Gottlieb outlines provisions in four guidances to help advance the agencys Biosimilars Action Plan.

HHS Sued Over Trial Reporting Rule

[ Price : $8.95]

Former FDAer Peter Lurie and journalism professor Charles Seife sue HHS, FDA, and NIH to overturn a final rule allowing some drug ...

Biomarker Qualification Draft Guidance

[ Price : $8.95]

FDA issues a draft guidance on the evidentiary framework it recommends for biomarker qualification under the 21st Century Cures Ac...

Amino Acid Polymer Product Assessment

[ Price : $8.95]

CDER issues a MAPP on procedures for integrated quality assessment of products containing drug substances composed of amino acid p...

Latest FDA Warning Letters

[ Price : $8.95]

FDA releases its latest batch of Warning Letters that include Skylark CMC and Zhejiang Huahai Pharmaceutical.

Dishman Carbogen FDA-483

[ Price : $8.95]

FDA released an FDA-483 with two observations issued to Dishman Carbogen Amcis in Gujarat, India.

Stakeholders Urge Congress to Axe the Device Tax

[ Price : $8.95]

More than 140 industry and advocacy groups urge Congress to permanently repeal the medical device tax before the end of this year.

CMC Human Gene Therapy Guidance Inadequate: PhRMA

[ Price : $8.95]

Stakeholders say a draft FDA guidance on CMC information for human gene therapy needs to be clarified and reorganized.